Skip to content

Collegium Pharmaceutical, Inc. COLL Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$22M-40.5%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$1.86M-13.9%
Avanos Medical logo
Avanos MedicalAVNS
$39.3M+22.4%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$39.41M-19.1%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$26.4M+16.2%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$23M-16.1%

Segments

By geography

See full
Stoughton, Massachusetts$4.17M

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s operating lease ROU assets?
Collegium Pharmaceutical, Inc. (COLL) reported operating lease ROU assets of $3.98M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s operating lease ROU assets changed year-over-year?
Collegium Pharmaceutical, Inc.'s operating lease ROU assets decreased by 28.3% year-over-year, from $5.55M to $3.98M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s operating lease ROU assets has grown at a -13.0% compound annual growth rate (CAGR), from $8.39M to $4.19M.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.